Skip to main navigation Skip to search Skip to main content

Phase 2 Study of ABT-122, a TNF- and IL-17A-Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response.

  • Philip Mease
  • , Mark C Genovese
  • , Michael E Weinblatt
  • , Paul M Peloso
  • , Kun Chen
  • , Ahmed A Othman
  • , Yihan Li
  • , Heikki T Mansikka
  • , Amit Khatri
  • , Neil Wishart
  • , John Liu

Research output: Contribution to journal › Article › peer-review

Original languageAmerican English
JournalArthritis Rheumatism
StatePublished - Jan 1 2018

Disciplines

  • Medicine and Health Sciences
  • Immunology and Infectious Disease

Cite this